By Faris Q.B. Alenzi Today, treatment options for cancer patients typically include surgery, radiation therapy, immunotherapy, and chemotherapy. While these therapies have saved lives and reduced pain and suffering, cancer still takes millions of lives every year around the world. Researchers are now developing advanced therapeutic strategies such as immunotherapy, targeted therapy, and combination nanotechnology for drug delivery. In addition, the identification of new biomarkers will potentiate early-stage diagnosis.Molecular Targets and Cancer presents information about cancer diagnosis and therapy in a simple way. It covers several aspects of the topic with updated information on par with medical board levels. The book features contributions from experts and includes an overview of cancer from basic biology and pathology, classifications, surveillance, prevention, diagnosis, types of cancer, treatment and prognosis.The first part of this book introduces the reader to cancer epidemiology, genetic alterations in cancer, exogenous and endogenous factors in carcinogenesis, roles for growth factors in cancer progression, cell signaling in cancer, transcription factors in cancer, and cancer genetics and epigenetics.This comprehensive guide is a valuable resource for oncologists, researchers, and all medical professionals who work in cancer care and research.
Product Details
Publisher : Bentham Science Publishers (April 20, 2023)
Language : English
Hardcover : 388 pages
ISBN-10 : 9815080393
ISBN-13 : 978-9815080391

Core Concepts in Pharmacology (5th Edition)
Dilemma's bij dementie
Insall & Scott Cirurgia do Joelho
101+ Careers in Public Health, 2nd Edition
Clinical Research: From Proposal to Implementation
Human Brain Stem Vessels: Including the Pineal Gland and Information on Brain Stem Infarction 2nd ed. 1999 Edition
Physical Medicine and Rehabilitation: An Update for Internists, An Issue of Medical Clinics of North America (Volume 104-2) (The Clinics: Internal Medicine, Volume 104-2) 


Reviews
There are no reviews yet.